Substituted pyridinylamino 1H-indazoles
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 12, 1994
Issued Date -
N/A
app pub date -
Mar 25, 1993
filing date -
Sep 23, 1991
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
This invention relates to substituted pyridinylamino-1H-indoles, 1H-indazoles, 2H-indazoles, benzo[b]thiophenes and 1,2-benzisothiazoles of the formula ##STR1## wherein Q is S, N or NR.sub.2 ; Y is CH, N or NR.sub.2 ; R.sub.1 is hydrogen, loweralkyl, loweralkynyl, loweralkenyl, arylloweralkyl, loweralkoxycarbonylaminoloweralkylcarbonyl, arylloweralkoxycarbonylaminoloweralkylcarbonyl, aminoloweralkylcarbonyl, loweralkoxycarbonyl or acyl; R.sub.2 is hydrogen or loweralkyl; R.sub.3 is hydrogen or loweralkyl; X is hydrogen, loweralkyl, halogen; and n is 0 or 1; or a pharmaceutically acceptable acid addition salt thereof. The compounds of this invention are useful in the treatment of memory dysfunctions characterized by a cholinergic deficit such as the type associated with Alzheimer's disease and other memory disorders. Compounds of this invention also have utility as modulators of neurotransmitter function such as noradrenergic and serotonergic and as such are useful for treatment of depression and personality disorders such as obsessive compulsive disorders. Additionally, compounds of this invention are useful as topical antiinflammatory agents for the treatment of various dermatoses.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
HOECHST-ROUSSEL PHARMACEUTICALS INC | SOMERVILLE NJ |
International Classification(s)
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Effland, Richard C | Bridgewater, NJ | 115 | 599 |
# of filed Patents : 115 Total Citations : 599 | |||
Klein, Joseph T | Bridgewater, NJ | 86 | 533 |
# of filed Patents : 86 Total Citations : 533 | |||
Martin, Lawrence L | Lebanon, NJ | 89 | 734 |
# of filed Patents : 89 Total Citations : 734 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 1 Citation Count
- A61K Class
- 12.34 % this patent is cited more than
- 31 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Jan 05, 2006 | FPAY | FEE PAYMENT | year of fee payment: 12 |
Dec 18, 2001 | FPAY | FEE PAYMENT | year of fee payment: 8 |
Dec 31, 1997 | FPAY | FEE PAYMENT | year of fee payment: 4 |
Dec 01, 1997 | FEPP | FEE PAYMENT PROCEDURE | free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
Dec 06, 1996 | FEPP | FEE PAYMENT PROCEDURE | free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
Jul 12, 1994 | I | Issuance | |
Mar 25, 1993 | F | Filing | |
Mar 25, 1993 | STPP | INFORMATION ON STATUS: PATENT APPLICATION AND GRANTING PROCEDURE IN GENERAL | free format text: APPLICATION UNDERGOING PREEXAM PROCESSING |
Sep 23, 1991 | PD | Priority Date |

Matter Detail

Renewals Detail
